Availability and reimbursement of biological products for severe asthma in Bulgaria

Availability and reimbursement of biological products for severe asthma in Bulgaria

Objectives: This study aims to analyze the reimbursement and cost of biological therapy for severe asthma in Bulgaria during 2014–2019 from the perspective of the National Health Insurance Fund. Methods: It is a retrospective, Marco-costing, top-down study of the expenditures for biological products...

Full description

Bibliographic Details
Main Authors:	Petya Milushewa, Miglena Doneva, Guenka Petrova
Format:	Article
Language:	English
Published:	SAGE Publishing 2020-08-01
Series:	SAGE Open Medicine
Online Access:	https://doi.org/10.1177/2050312120951067

Similar Items

Biosimilar Insulins and Their Impact on Prices and Utilization of Insulins in Bulgaria
by: Konstantin Tachkov, et al.
Published: (2021-06-01)

Pilot Study on the Cost of Some Oncohematology Diseases in Bulgaria
by: Konstantin Tachkov, et al.
Published: (2019-03-01)

An Overview of the Reimbursement Decision-Making Processes in Bulgaria As a Reference Country for the Middle-Income European Countries
by: Maria Kamusheva, et al.
Published: (2018-03-01)

Cardiovascular co-morbidity in patients with COPD in Bulgaria
by: Maria Dimitrova, et al.
Published: (2020-01-01)

New Epidemiological, Clinical and Economic Data for Patients With Acromegaly in Bulgaria
by: Maria Kamusheva, et al.
Published: (2020-04-01)

Analysis of the Household and Health Care System Expenditures in Bulgaria
by: Zornitsa Mitkova, et al.
Published: (2021-07-01)

Improved quality of diabetes control reduces complication costs in Bulgaria
by: Konstantin Tachkov, et al.
Published: (2019-01-01)

Generics and fixed-dose combinations in cardiology: satisfaction analysis of pharmacists and cardiologists
by: Guenka Petrova, et al.
Published: (2016-01-01)

Criteria for Drug Reimbursement Decision-Making: An Emerging Public Health Challenge in Bulgaria
by: Georgi Iskrov, et al.
Published: (2016-02-01)

Did the Introduction of Biosimilars Influence Their Prices and Utilization? The Case of Biologic Disease Modifying Antirheumatic Drugs (bDMARD) in Bulgaria
by: Konstantin Tachkov, et al.
Published: (2021-01-01)

COVID-19 pandemic impact on the pharmaceutical sector in Bulgaria
by: Veselina Ivanova, et al.
Published: (2021-09-01)

Life expectancy and survival analysis of patients with diabetes compared to the non diabetic population in Bulgaria.
by: Konstantin Tachkov, et al.
Published: (2020-01-01)

Anti-Odysseus: Orphism and Late Communism in Bulgaria
by: Nikolchina, Miglena
Published: (2018-07-01)

Rare disease patients’ needs: an up-to-date analysis and future directions
by: Maria Kamusheva, et al.
Published: (2021-10-01)

Generic policy in Bulgaria: a policy of failure or success?
by: Assena Stoimenova, et al.
Published: (2016-09-01)

Cost-effectiveness analysis of current treatment of individuals with acute exacerbation of schizophrenia in Bulgaria
by: Desislava Ignatova, et al.
Published: (2019-01-01)

Pricing and Reimbursement of Biosimilars in Central and Eastern European Countries
by: Paweł Kawalec, et al.
Published: (2017-06-01)

Psychological Aspects of Civic Protests in Bulgaria
by: Petya Stoyanova Pachkova
Published: (2016-10-01)

Chronic Hepatitis C-Related Cirrhosis Hospitalization Cost Analysis in Bulgaria
by: Maria Dimitrova, et al.
Published: (2017-08-01)

Trends in business processes management in the furniture industry in Bulgaria
by: Slavova Petya
Published: (2021-01-01)

Challenges to Europeanization : the transposition and implementation of EU waste 'acquis' in Bulgaria
by: Dragneva, Petya
Published: (2011)

Biological therapy for severe asthma
by: Silvano Dragonieri, et al.
Published: (2021-08-01)

Biological treatments for severe asthma
by: Hyun Jung Jin
Published: (2020-10-01)

A New Case of Schnitzler Syndrome in Bulgaria
by: Kirilova-Doneva M., et al.
Published: (2018-12-01)

The impact of reimbursement negotiations on cost and availability of new pharmaceuticals: evidence from an online experiment
by: Dominik J. Wettstein, et al.
Published: (2020-05-01)

Аn affordability of statins therapy - comparative analysis between Ukraine and Bulgaria
by: Oksana Tkachova, et al.
Published: (2019-11-01)

Possible benefits from greening of public transport stops in Sofia, Bulgaria
by: Mariam Bozhilova, et al.
Published: (2021-07-01)

Pharmacotherapeutic Patterns and Patients’ Access to Pharmacotherapy for Some Rare Diseases in Bulgaria – A Pilot Comparative Study
by: Maria Kamusheva, et al.
Published: (2021-07-01)

A Capability Perspective on Employability of Higher Education Graduates in Bulgaria
by: Petya Ilieva-Trichkova
Published: (2014-10-01)

Reimbursement process of medicinal products in Poland and in the world
by: Aneta Katarzyna Mela
Published: (2020-09-01)

Economic and pharmaco-economic analysis of acromegaly treatment: a systematic review
by: Maria Kamusheva, et al.
Published: (2019-01-01)

Biologic Therapy and Severe Asthma in Children
by: Daniele Russo, et al.
Published: (2021-06-01)

IMPLEMENTATION OF EU DIRECTIVES FOR CERTIFICATION OF THE STAFF IN THE SPA BUSINESS IN BULGARIA
by: Petya Kutincheva, et al.
Published: (2013-07-01)

Omalizumab, the first available antibody for biological treatment of severe asthma: more than a decade of real-life effectiveness
by: Corrado Pelaia, et al.
Published: (2018-11-01)

Green roofs and green walls &ndash; legislative framework in Bulgaria
by: Mariam Bozhilova, et al.
Published: (2020-10-01)

The History of Reimbursements in Neurology
by: Shaheen E Lakhan, et al.
Published: (2013-11-01)

Health technology assessment and reimbursement policy for oncology orphan drugs in Central and Eastern Europe
by: Krzysztof Piotr Malinowski, et al.
Published: (2020-10-01)

Biological treatments for severe asthma: A major advance in asthma care
by: William W. Busse
Published: (2019-04-01)

Molecular Targets for Biological Therapies of Severe Asthma
by: Corrado Pelaia, et al.
Published: (2020-11-01)

Reimbursement Legislations and Decision Making for Orphan Drugs in Central and Eastern European Countries
by: Krzysztof Piotr Malinowski, et al.
Published: (2019-05-01)